Vincerx Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-40.16	-62.98	-39.31	-16.62
Depreciation & Amortization	0.92	0.94	0.34	0
Share-Based Compensation	3.56	10.06	23.31	4.38
Other Operating Activities	-4.77	-7.62	-17.75	9.96
Operating Cash Flow	-40.45	-59.6	-33.4	-2.28
Capital Expenditures	0	0	-5.26	0
Change in Investments	41.5	-40.58	0	0
Investing Cash Flow	41.5	-40.58	-5.26	0
Share Issuance / Repurchase	0.11	0.28	88.45	64.07
Financing Cash Flow	0.11	0.28	88.45	64.07
Exchange Rate Effect	-0.04	0.07	-0.02	0
Net Cash Flow	1.12	-99.83	49.77	61.79
Free Cash Flow	-40.45	-59.6	-38.66	-2.28
Free Cash Flow Per Share	-1.90	-2.83	-2.25	-0.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).